Seoul national university bundang hospital
Seongnam-si, Gyeonggi-do, South Korea
NCT Number: NCT01360060
Magnesium sulphate is the first line therapy for the management of preeclampsia and eclampsia in obstetrics. Perioperative administration of magnesium sulphate has been proved to be an effective as an analgesic adjuvant. The investigators evaluated the analgesic effect of magnesium in parturients undergoing Cesarean section.
Looking for future studies?
Notify Me20 year–50 year
Female
Observational
Seongnam-si, Gyeonggi-do, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Magnesium sulphate was infused for the management of preeclampsia at perioperative period.
Time frame: postoperative 1, 2, 3, and 4 day
Time frame: during postoperative 4 days
Time frame: preoperative 1 h and postoperative 1 day
Seoul National University Bundang Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04974892
Female Urogenital Diseases and Pregnancy Complications, Hypertension, Pregnancy-Induced
London, United Kingdom
View Trial DetailsNCT01648842
Avitaminosis, Deficiency Diseases
Clamart, France
View Trial DetailsNCT00344058
Female Urogenital Diseases and Pregnancy Complications, Hypertension, Pregnancy-Induced
Cleveland, Ohio, United States
View Trial DetailsNCT02791568
Body Weight, Female Urogenital Diseases and Pregnancy Complications
Madison, Wisconsin, United States
View Trial Details